Human Microbiome Therapeutics Market

The human microbiome therapeutics market consists of medical treatments designed to restore or modify the body's community of microorganisms to manage diseases. Key customers are patients suffering from a wide range of conditions, including gastrointestinal disorders, cancer, metabolic disorders, and skin conditions, with treatments delivered via healthcare systems. Growth is primarily driven by the rising incidence of chronic diseases, growing antibiotic resistance, and significant technological advances in microbiome sequencing, synthetic biology, and personalized medicine.